Aastrom Biosciences, Inc. Announces Investor Conference Call And Webcast June 16, 2014 At 8:30 AM EDT

ANN ARBOR, Mich., June 15, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and conditions, will hold an investor conference call and slide presentation on Monday, June 16, 2014 beginning at 8:30 AM EDT. The company will present an update and its strategic plans for the cell therapy and regenerative medicine business that it recently acquired from Sanofi.

Help employers find you! Check out all the jobs and post your resume.